- Home
- BMY vs SBUX Comparison
BMY vs SBUX Comparison
Compare BMY & SBUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- SBUX
- Stock Information
- Founded
- BMY 1887
- SBUX 1971
- Country
- BMY United States
- SBUX United States
- Employees
- BMY N/A
- SBUX N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- SBUX Restaurants
- Sector
- BMY Health Care
- SBUX Consumer Discretionary
- Exchange
- BMY Nasdaq
- SBUX Nasdaq
- Market Cap
- BMY 94.0B
- SBUX 95.8B
- IPO Year
- BMY N/A
- SBUX 1992
- Fundamental
- Price
- BMY $45.09
- SBUX $79.71
- Analyst Decision
- BMY Hold
- SBUX Buy
- Analyst Count
- BMY 15
- SBUX 24
- Target Price
- BMY $57.64
- SBUX $101.04
- AVG Volume (30 Days)
- BMY 18.1M
- SBUX 9.7M
- Earning Date
- BMY 10-30-2025
- SBUX 10-29-2025
- Dividend Yield
- BMY 5.57%
- SBUX 3.05%
- EPS Growth
- BMY N/A
- SBUX N/A
- EPS
- BMY 2.49
- SBUX 2.31
- Revenue
- BMY $47,704,000,000.00
- SBUX $36,689,300,000.00
- Revenue This Year
- BMY N/A
- SBUX $4.46
- Revenue Next Year
- BMY N/A
- SBUX $6.28
- P/E Ratio
- BMY $17.92
- SBUX $34.66
- Revenue Growth
- BMY 2.57
- SBUX 0.58
- 52 Week Low
- BMY $42.96
- SBUX $75.50
- 52 Week High
- BMY $63.33
- SBUX $117.46
- Technical
- Relative Strength Index (RSI)
- BMY 45.11
- SBUX 36.57
- Support Level
- BMY $44.25
- SBUX $83.96
- Resistance Level
- BMY $48.58
- SBUX $87.26
- Average True Range (ATR)
- BMY 1.11
- SBUX 1.75
- MACD
- BMY 0.03
- SBUX -0.29
- Stochastic Oscillator
- BMY 31.54
- SBUX 10.90
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About SBUX Starbucks Corporation
Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 40,000 stores across more than 80 countries at the end of March 2025. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage). The coffee chain generates revenue from company-operated stores, royalties, sales of equipment and products to license partners, ready-to-drink beverages, packaged coffee sales, and single-serve products.